Adaptive Biotechnologies Corporation Common Stock
ADPT Real Time Price USDRecent trades of ADPT by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ADPT's directors and management
Government lobbying spending instances
-
$30,000 Jan 19, 2024 Issue: Health Issues
-
$30,000 Oct 16, 2023 Issue: Medicare/Medicaid Budget/Appropriations Health Issues
-
$60,000 Jul 18, 2023 Issue: Medicare/Medicaid Budget/Appropriations Health Issues
-
$70,000 Jan 18, 2023 Issue: Medicare/Medicaid Budget/Appropriations Health Issues
-
$80,000 Oct 17, 2022 Issue: Medicare/Medicaid Budget/Appropriations Health Issues
-
$70,000 Jul 12, 2022 Issue: Budget/Appropriations Health Issues Medicare/Medicaid
-
$240,000 Mar 23, 2022 Issue: Medicare/Medicaid Health Issues
-
$190,000 Jan 21, 2022 Issue: None
-
$140,000 Oct 20, 2021 Issue: None
-
$120,000 Jul 15, 2021 Issue: None
-
$130,000 Apr 20, 2021 Issue: HEALTH ISSUES
-
$190,000 Jan 21, 2021 Issue: HEALTH ISSUES
-
$80,000 Oct 20, 2020 Issue: Health Issues Medicare/Medicaid
-
$50,000 Jul 20, 2020 Issue: Medicare/Medicaid Health Issues
-
$30,000 Apr 20, 2015 Issue: Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of ADPT in WallStreetBets Daily Discussion
Recent insights relating to ADPT
Recent picks made for ADPT stock on CNBC
ETFs with the largest estimated holdings in ADPT
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ADPT Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.